8.35 -0.02 (-0.24%)
ATRC
Stock Details
Last Trade:8.35 Change:-0.02 (-0.24%) Prev Close:8.37 Open: 8.36 Days Range:8.35 – 8.43 52 Week Range: 8.16 - 14.38 Volume:13302 P/E: N/AEPS:-0.64
View AllRecent Alerts 10/07/08
Recent Alert on 08/12/08 at 12:03pm
Canaccord Adams Starts AtriCure (ATRC) at Buy; $15 PT
Canaccord Adams Starts AtriCure (ATRC) at Buy; $15 PT
Canaccord Adams initiates coverage on AtriCure (Nasdaq: ATRC) with a Buy rating and a $15 price target. The firm calls AtriCure an "A-Fib pure play" that will be a winner in this market. Canaccord is estimating a CAGR of 25%+ through 2012 for the... Read More
Recent Alert on 08/05/08 at 8:42am
AtriCure (ATRC) Reports Q2 Loss of $0.11, Beats by 6c; Reaffirms FY08 Guidance
AtriCure (ATRC) Reports Q2 Loss of $0.11, Beats by 6c; Reaffirms FY08 Guidance
Recent Alert on 08/05/08 at 8:42am
AtriCure (ATRC) Reports Q2 Loss of $0.11, Beats by 6c; Reaffirms FY08 Guidance
AtriCure (ATRC) Reports Q2 Loss of $0.11, Beats by 6c; Reaffirms FY08 Guidance
Recent Alert on 08/05/08 at 8:42am
AtriCure (ATRC) Reports Q2 Loss of $0.11, Beats by 6c; Reaffirms FY08 Guidance
AtriCure (ATRC) Reports Q2 Loss of $0.11, Beats by 6c; Reaffirms FY08 Guidance
View AllRecent Press Releases
Press Release on 10/07/08 at 12:59pm
Wall Street Media Presents Exclusive Videos from the JMP Healthcare Focus Conference
Wall Street Media Presents Exclusive Videos from the JMP Healthcare Focus Conference
Press Release on 10/06/08 at 4:15pm
AtriCure Announces Web Cast and Conference Call of Third Quarter 2008 Financial Results
AtriCure Announces Web Cast and Conference Call of Third Quarter 2008 Financial Results
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 04/15/08 at 6:32am
AtriCure, Micrus Endovascular, BioSphere: Strong Outlook with New Technologies
AtriCure, Micrus Endovascular, BioSphere: Strong Outlook with New Technologies